Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,041.7
-29.5 (-0.96%)

 

  • STI Straits Times Index
    3,041.7
    -29.5 (-0.96%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.9
    -20.6 (-1.33%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,099.1
    -821.6 (-3.30%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,323.3
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,076.3
    -56.9 (-0.93%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,423.4M
  • Value: 1,459.2M
  • Rise: 78
  • Fall: 304
  • Unch: 373

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.065-0.008
Sembcorp Marine0.082-0.002
Medi Lifestyle0.033-0.001
Singtel2.440+0.010
CapLand IntCom T2.000-
YZJ Shipbldg SGD1.440-0.040
Intl Cement0.031-0.002
Jiutian Chemical0.077-0.005
VCPlus0.027+0.001
CapitaLandInvest2.950-

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,099.1 -821.6
HSCEI 8,638.5 -301.9
Jakarta 6,076.3 -56.9
Nikkei 225 30,323.3
SSE Comp 3,614.0
Shanghai A 3,787.7
Shanghai B 273.1
KOSPI 3,130.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ENSYSCE BIOSCIENCES INC ENSYSCE BIOSCIENCES
Updated on 17 Sep 2021 (End of trading day)
Last (USD): 2.950 Change: -0.160 High: 3.660 Remarks: -
Change (%): -5.14 Low: 2.950
Open 3.120 Yesterday's Close 3.1100000000000003
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 806,183 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.17772 Trailing EPS (USD) e 0.12158 NAV (USD) b 0.0781
PE a 16.599 Trailing PE f 24.264 Price / NAV b 37.7721
Dividend (USD) d - Cash In Hand (USD) g 0.0007 Issued & Paid-up Shares c 24,255,800
Dividend Yield (%) d - Price / Cash In Hand g 4,214.286 Treasury Shares h -
Market Cap (M) 71.555 Enterprise Value (M) 71.997
Piotroski F Score 6 Exchange Code ENSC Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 39.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 18 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Jul 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ENSYSCE BIOSCIENCES INC NASDAQ 71.555 16.599 24.264 37.7721 -
Industry Biotechnology NASDAQ 3,132.697 106.306 106.381 7.1432 0.528
Local Peer MODERNA INC NASDAQ 173,587.962 - 49.669 25.8932 -
Local Peer AMGEN INC NASDAQ 124,575.372 17.150 21.680 15.1055 2.971
Local Peer GILEAD SCIENCES INC NASDAQ 89,785.334 729.969 17.394 4.5569 3.799
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 86,749.513 5,007.389 17.664 13.3419 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 69,721.806 19.846 11.236 4.6090 -
Local Peer ILLUMINA INC NASDAQ 65,576.367 99.964 85.386 12.6595 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 48,850.292 18.015 24.527 5.3119 -
Local Peer BIOGEN INC NASDAQ 44,738.216 11.183 23.324 4.1610 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 37,507.057 - - 10.3993 -
Local Peer SEAGEN INC NASDAQ 28,419.910 46.311 47.583 8.3803 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 22,621.528 - - 26.5086 -
Local Peer BIO-TECHNE CORP NASDAQ 20,966.986 149.418 149.418 13.4148 0.238
Other Local Peers EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), NOVAVAX INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EXELIXIS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CORTEXYME INC (NASDAQ), INSTIL BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SEER INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), XENCOR INC (NASDAQ), REGENXBIO INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NUVALENT INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), UNIQURE N.V. (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), ALLOVIR INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), KADMON HLDGS INC (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), HUMACYTE INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), MAXCYTE INC (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), INHIBRX INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), AGENUS INC (NASDAQ), DICE THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), VAXCYTE INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MACROGENICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), BIOATLA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), GRAPHITE BIO INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), FIBROGEN INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), VAXART INC (NASDAQ), OMEGA THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), IMMUNOVANT INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), PERSONALIS INC (NASDAQ), MERUS B V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMATICS N V (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SHATTUCK LABS INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), ANAPTYSBIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PASSAGE BIO INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), AADI BIOSCIENCE INC (NASDAQ), ALTIMMUNE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), EPIZYME INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), COMPUGEN (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHIMERIX INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ELIEM THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), 22ND CENTURY GROUP INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), AKOUOS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), HUMANIGEN INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), INMUNE BIO INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ATYR PHARMA INC (NASDAQ), AVROBIO INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ONCORUS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), KAMADA LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ATRECA INC (NASDAQ), ADICET BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), MEDICINOVA INC (NASDAQ), EQUILLIUM INC (NASDAQ), CARDIOL THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), SESEN BIO INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), IMV INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ARDELYX INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), IN8BIO INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), HCW BIOLOGICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ORGENESIS INC (NASDAQ), EXICURE INC (NASDAQ), EVOGENE LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ASTRIA THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INFLARX N V (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), OTONOMY INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ARAVIVE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), STATERA BIOPHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), METACRINE INC (NASDAQ), BON NAT LIFE LTD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), COHBAR INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ),